Publications by authors named "Mehdi Adib"

Claim this Profile
C
Copper Supported Imidazolylpyridine Modified SPION as an Efficient Catalyst for Eco-friendly, One-pot and Green Synthesis of Novel (3- Cyanothiophen-2-yl)-N-(arylsulfonyl)acetimidamide Derivatives.
Mohammad Askarzadeh, Mehdi Adib, Mohammad Mahdavi

Curr Org Synth· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palladium supported magnetic Fucus Vesiculosus extract as a natural and novel catalyst for the synthesis of N-alkyl-2-(4-methyl-1-oxoisoquinolin-2(1H)-yl)-2-phenylacetamide derivatives.
Faeze Yousefnejad, Saeed Bahadorikhalili, Maryam Esmkhani, Mehdi Adib, Shahrzad Javanshir

Sci Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based drug discovery and antimicrobial activity of ciprofloxacin-grafted Ugi adducts.
Behnam Tahmasebi, Aida Iraji, Maedeh Sherafati, Ali Moazzam, Seyed Alireza Akhlagh, Mehdi Adib

J Biomol Struct Dyn· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effects of disubstituted 3-hydroxy-1H-pyrrol-2(5H)-one analog as novel tyrosinase inhibitors.
Naiemeh Alizadeh, Mohammad Hossein Sayahi, Aida Iraji, Rozita Yazzaf, Ali Moazzam, Mehdi Adib

Bioorg Chem· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The possible effect of microRNA-155 (miR-155) and BACE1 inhibitors in the memory of patients with down syndrome and Alzheimer's disease: Design, synthesis, virtual screening, molecular modeling and biological evaluations.
Shabnam Mahernia, Malihe Hassanzadeh, Mehdi Adib, Fariba Peytam, Zahra Haghighijoo

J Biomol Struct Dyn· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes.
Mohammad Askarzadeh, Homa Azizian, Mehdi Adib, Maryam Mohammadi-Khanaposhtani, Somayeh Mojtabavi

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic-based cancer therapeutics: new potential HDAC8 inhibitors.
Malihe Hassanzadeh, Shabnam Mahernia, Gianluca Caprini, Gianluca Fossati, Mehdi Adib

J Biomol Struct Dyn· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.
Fariba Peytam, Mehdi Adib, Reihaneh Shourgeshty, Maryam Mohammadi-Khanaposhtani, Mehdi Jahani

Mol Divers· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity.
Fariba Peytam, Mehdi Adib, Reihaneh Shourgeshty, Loghman Firoozpour, Mahmoud Rahmanian-Jazi

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoindolin-1-one derivatives as urease inhibitors: Design, synthesis, biological evaluation, molecular docking and in-silico ADME evaluation.
Fariba Peytam, Mehdi Adib, Shabnam Mahernia, Mahmoud Rahmanian-Jazi, Mehdi Jahani

Bioorg Chem· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.
Mehdi Adib, Fariba Peytam, Reihaneh Shourgeshty, Maryam Mohammadi-Khanaposhtani, Mehdi Jahani

Bioorg Med Chem Lett· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.
Mehdi Adib, Fariba Peytam, Mahmoud Rahmanian-Jazi, Shabnam Mahernia, Hamid Reza Bijanzadeh

Eur J Med Chem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based pharmacophore design and virtual screening for novel potential inhibitors of epidermal growth factor receptor as an approach to breast cancer chemotherapy.
Shabnam Mahernia, Malihe Hassanzadeh, Niusha Sharifi, Bita Mehravi, Fariba Paytam, Mehdi Adib

Mol Divers· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
Mohammad Mahdavi, Keyvan Pedrood, Maliheh Safavi, Mina Saeedi, Mahboobeh Pordeli, Mehdi Adib

Eur J Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extraction and determination of 2-pyrazoline derivatives using liquid phase microextraction based on solidification of floating organic drop.
Hamid Reza Sobhi, Yadollah Yamini, Ali Esrafili, Mehdi Adib

J Pharm Biomed Anal· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient Ce(NO3)3 x 6H2O-catalyzed solvent-free synthesis of 3,4-dihydropyrimidin-2(1H)-ones.
Mehdi Adib, Khadijeh Ghanbary, Manizheh Mostofi, Mohammad Reza Ganjali

Molecules· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis